ProShares UltraShort Nasdaq Biotechnology (BIS) Holdings $19.04 -0.03 (-0.16%) As of 05/23/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestTrendsBuy This Stock Top 7 BIS HoldingsRankCompanyCurrent PriceWeightShares Held1NET OTHER ASSETS (LIABILITIES)N/A0.00%2,806,6882TREASURY BILLN/A0.00%100,0003NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A-32.74%-2344NASDAQ BIO INDEX SWAP BNP PARIBASN/A-35.82%-2565NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A-40.29%-2886NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A-43.37%-3107NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A-47.71%-341 Geographic ExposureUnited States3.5%Currency ExposureUSD80.0% Related Companies and Tools Related Companies JPMorgan Healthcare Leaders ETF Holdings Horizon Kinetics Medical ETF Holdings First Trust Nasdaq Pharmaceuticals ETF Holdings Invesco Nasdaq Biotechnology ETF Holdings Global X HealthTech ETF Holdings ProShares Ultra Nasdaq Biotechnology Holdings F/m Emerald Life Sciences Innovation ETF Holdings Invesco Dorsey Wright Healthcare Momentum ETF Holdings Invesco S&P SmallCap Health Care ETF Holdings VanEck Biotech ETF Holdings This page (NASDAQ:BIS) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
